What is Bioventus's revenue?

Bioventus (BVS) generated $576.3M in revenue over the trailing twelve months, up 1.5% year over year.

Is Bioventus profitable?

Bioventus reported $28.5M in net income over the trailing twelve months, a 4.9% net margin.

What are Bioventus's profit margins?

Gross margin is 68.7% and operating margin is 10.0%, with a 4.9% net margin.

What is Bioventus's earnings per share?

Bioventus's diluted EPS over the trailing twelve months is $0.41.

Where does Bioventus's income statement data come from?

Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Bioventus BVS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$576.3M+1.4%	$568.09M+0.8%	$563.83M-0.1%	$564.14M-0.6%	$567.7M-1.0%
Total cost of revenue	$180.43M+0.3%	$179.93M-1.0%	$181.8M-0.5%	$182.79M-1.1%	$184.8M-0.1%
Gross profit	$395.87M+2.0%	$388.16M+1.6%	$382.03M+0.2%	$381.35M-0.4%	$382.9M-1.4%
Gross margin	68.7%+0.4pp	68.3%+0.6pp	67.8%+0.2pp	67.6%+0.2pp	67.4%-0.3pp
Research and development	$11.57M-4.5%	$12.11M-2.1%	$12.38M-6.9%	$13.3M-7.2%	$14.34M+2.8%
Selling, general and administrative	$318.85M+1.5%	$314.03M-1.3%	$318.14M-0.9%	$320.97M-5.2%	$338.53M-1.5%
Operating income	$57.52M+6.6%	$53.98M—	——	——	——
Operating margin	10%+0.5pp	9.5%—	——	——	——
Interest expense	-$23.3M+12.0%	-$26.49M+12.2%	-$30.18M+10.0%	-$33.53M+6.8%	-$35.96M+7.3%
Other income (expense), net	-$23.88M+15.5%	-$28.27M+7.9%	-$30.68M+7.0%	-$33M+5.8%	-$35.03M+5.7%
Income before income taxes	$33.64M+30.9%	$25.71M+123%	$11.51M+627%	$1.58M+103%	-$50.29M+3.9%
Income tax expense	-$899K+42.6%	-$1.57M—	——	——	——
Net income	$28.48M+25.3%	$22.73M+200%	$7.59M+1,138%	-$731K+97.8%	-$33.87M+6.2%
Net margin	4.9%+0.9pp	4%+2.7pp	1.3%+1.5pp	-0.1%+5.8pp	-6%+0.3pp
Diluted earnings per share	$0.41+24.2%	$0.33+175%	$0.12+1,300%	-$0.01+98.1%	-$0.52+7.1%
EBITDA	$103.87M+2.9%	$100.99M+38.0%	$73.16M+10.1%	$66.43M+277%	$17.63M+0.1%
EBITDA margin	18%+0.2pp	17.8%+4.8pp	13%+1.2pp	11.8%+8.7pp	3.1%0.0pp
EBIT	$57.52M+6.6%	$53.98M+112%	$25.44M+42.6%	$17.83M+156%	-$32.01M-0.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bioventus.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's revenue?: Bioventus (BVS) generated $576.3M in revenue over the trailing twelve months, up 1.5% year over year.
Is Bioventus profitable?: Bioventus reported $28.5M in net income over the trailing twelve months, a 4.9% net margin.
What are Bioventus's profit margins?: Gross margin is 68.7% and operating margin is 10.0%, with a 4.9% net margin.
What is Bioventus's earnings per share?: Bioventus's diluted EPS over the trailing twelve months is $0.41.
Where does Bioventus's income statement data come from?: Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.